IL6 and neoplasm: This view was supported by Huang et al. [120] who pointed out that co-injection of human colorectal cancer cells and MSCs into nude mice could promote angiogenesis and tumor growth, resulting from MSCs-derived IL-6 induced the enrichment of proangiogenic factors secreted by cancer cells.